Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3864

1.

Tau-based therapies in neurodegeneration: opportunities and challenges.

Li C, Götz J.

Nat Rev Drug Discov. 2017 Oct 6. doi: 10.1038/nrd.2017.155. [Epub ahead of print] Review.

PMID:
28983098
2.

Research Gaps and Controversies in Chronic Traumatic Encephalopathy: A Review.

Asken BM, Sullan MJ, DeKosky ST, Jaffee MS, Bauer RM.

JAMA Neurol. 2017 Oct 1;74(10):1255-1262. doi: 10.1001/jamaneurol.2017.2396. Review.

PMID:
28975240
3.

Neuropathological comorbidity associated with argyrophilic grain disease.

Yokota O, Miki T, Ikeda C, Nagao S, Takenoshita S, Ishizu H, Haraguchi T, Kuroda S, Terada S, Yamada N.

Neuropathology. 2017 Sep 14. doi: 10.1111/neup.12429. [Epub ahead of print] Review.

PMID:
28906054
4.

Microglia emerge as central players in brain disease.

Salter MW, Stevens B.

Nat Med. 2017 Sep 8;23(9):1018-1027. doi: 10.1038/nm.4397. Review.

PMID:
28886007
5.

Vaccination strategies in tauopathies and synucleinopathies.

Braczynski AK, Schulz JB, Bach JP.

J Neurochem. 2017 Sep 4. doi: 10.1111/jnc.14207. [Epub ahead of print] Review.

PMID:
28869766
6.

Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Kulbe JR, Hall ED.

Prog Neurobiol. 2017 Aug 26. pii: S0301-0082(17)30047-3. doi: 10.1016/j.pneurobio.2017.08.003. [Epub ahead of print] Review.

PMID:
28851546
7.

Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies.

Kontaxi C, Piccardo P, Gill AC.

Front Mol Biosci. 2017 Aug 11;4:56. doi: 10.3389/fmolb.2017.00056. eCollection 2017. Review.

8.

The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.

Banerjee G, Carare R, Cordonnier C, Greenberg SM, Schneider JA, Smith EE, Buchem MV, Grond JV, Verbeek MM, Werring DJ.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):982-994. doi: 10.1136/jnnp-2016-314697. Epub 2017 Aug 26. Review.

9.

Amyloidogenesis of Tau protein.

Nizynski B, Dzwolak W, Nieznanski K.

Protein Sci. 2017 Aug 17. doi: 10.1002/pro.3275. [Epub ahead of print] Review.

PMID:
28833749
10.

Small-molecule PET Tracers for Imaging Proteinopathies.

Mathis CA, Lopresti BJ, Ikonomovic MD, Klunk WE.

Semin Nucl Med. 2017 Sep;47(5):553-575. doi: 10.1053/j.semnuclmed.2017.06.003. Epub 2017 Jul 13. Review.

PMID:
28826526
11.

Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.

Moussa CE.

Expert Opin Investig Drugs. 2017 Oct;26(10):1131-1136. doi: 10.1080/13543784.2017.1369527. Epub 2017 Aug 23. Review.

PMID:
28817311
12.

Resveratrol for Alzheimer's disease.

Sawda C, Moussa C, Turner RS.

Ann N Y Acad Sci. 2017 Sep;1403(1):142-149. doi: 10.1111/nyas.13431. Epub 2017 Aug 16. Review.

PMID:
28815614
13.

Association of <i>TCN2</i> rs1801198 c.776G&gt;C polymorphism with markers of one-carbon metabolism and related diseases: a systematic review and meta-analysis of genetic association studies.

Oussalah A, Levy J, Filhine-Trésarrieu P, Namour F, Guéant JL.

Am J Clin Nutr. 2017 Oct;106(4):1142-1156. doi: 10.3945/ajcn.117.156349. Epub 2017 Aug 16. Review.

PMID:
28814397
14.

[Pathophysiology of intracranial injuries].

Lahner D, Fritsch G.

Unfallchirurg. 2017 Aug 15. doi: 10.1007/s00113-017-0388-0. [Epub ahead of print] Review. German.

PMID:
28812113
15.

Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases.

Roubroeks JAY, Smith RG, van den Hove DLA, Lunnon K.

J Neurochem. 2017 Oct;143(2):158-170. doi: 10.1111/jnc.14148. Epub 2017 Sep 21. Review.

PMID:
28805248
16.

Current and future prospects of nuclear medicine in dementia.

Ito K, Inui Y, Kizawa T, Kimura Y, Kato T.

Rinsho Shinkeigaku. 2017 Sep 30;57(9):479-484. doi: 10.5692/clinicalneurol.cn-001016. Epub 2017 Aug 11. Review. Japanese.

PMID:
28804110
17.

PERK as a hub of multiple pathogenic pathways leading to memory deficits and neurodegeneration in Alzheimer's disease.

Ohno M.

Brain Res Bull. 2017 Aug 10. pii: S0361-9230(17)30393-3. doi: 10.1016/j.brainresbull.2017.08.007. [Epub ahead of print] Review.

PMID:
28804008
18.

Atypical parkinsonian syndromes: a general neurologist's perspective.

Deutschländer AB, Ross OA, Dickson DW, Wszolek ZK.

Eur J Neurol. 2017 Aug 12. doi: 10.1111/ene.13412. [Epub ahead of print] Review.

PMID:
28803444
19.

Tau-imaging in neurodegeneration.

Bischof GN, Endepols H, van Eimeren T, Drzezga A.

Methods. 2017 Aug 5. pii: S1046-2023(16)30402-9. doi: 10.1016/j.ymeth.2017.08.003. [Epub ahead of print] Review.

PMID:
28790016
20.

Emerging Diagnostic and Therapeutic Strategies for Tauopathies.

Coughlin D, Irwin DJ.

Curr Neurol Neurosci Rep. 2017 Sep;17(9):72. doi: 10.1007/s11910-017-0779-1. Review.

PMID:
28785992

Supplemental Content

Loading ...
Support Center